The Roles of NRF2-Regulated Oxidative Stress and Mitochondrial Quality Control in Chronic Liver Diseases
Antioxidants · 29.10.2023 · 12 (11) · 1928
DOI: 10.3390/antiox12111928 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antioxidants, online erschienen am 29.10.2023. Verfasst von Jeong-Su Park und 2 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy and Medical Research Center, Chungbuk National University, Cheongju 28160, Republic of Korea. Die Arbeit wurde bisher 74-mal zitiert (Crossref) und nennt 206 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Korean Food and Drug Administration, Regional Innovation Strategy (RIS) of the National Research Foundation of Korea.
Abstract (Originalsprache)
Chronic liver disease (CLD) affects a significant portion of the global population, leading to a substantial number of deaths each year. Distinct forms like non-alcoholic fatty liver disease (NAFLD) and alcoholic fatty liver disease (ALD), though they have different etiologies, highlight shared pathologies rooted in oxidative stress. Central to liver metabolism, mitochondria are essential for ATP production, gluconeogenesis, fatty acid oxidation, and heme synthesis. However, in diseases like NAFLD, ALD, and liver fibrosis, mitochondrial function is compromised by inflammatory cytokines, hepatotoxins, and metabolic irregularities. This dysfunction, especially electron leakage, exacerbates the production of reactive oxygen species (ROS), augmenting liver damage. Amidst this, nuclear factor erythroid 2-related factor 2 (NRF2) emerges as a cellular protector. It not only counters oxidative stress by regulating antioxidant genes but also maintains mitochondrial health by overseeing autophagy and biogenesis. The synergy between NRF2 modulation and mitochondrial function introduces new therapeutic potentials for CLD, focusing on preserving mitochondrial integrity against oxidative threats. This review delves into the intricate role of oxidative stress in CLD, shedding light on innovative strategies for its prevention and treatment, especially through the modulation of the NRF2 and mitochondrial pathways.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Pharmacy and Medical Research Center, Chungbuk National University, Cheongju 28160, Republic of Korea.
ORCID-Profile: Jeong-Su Park, Nodir Rustamov
Förderung
- National Research Foundation of Korea
- Korean Food and Drug Administration
- Regional Innovation Strategy (RIS) of the National Research Foundation of Korea
- Chungbuk National University BK21 program
- research year of Chungbuk National University in 2022
Zitieren
APA
Park, J. S., Rustamov, N., & Roh, Y. S. (2023). The Roles of NRF2-Regulated Oxidative Stress and Mitochondrial Quality Control in Chronic Liver Diseases. Antioxidants, 12(11), 1928. https://doi.org/10.3390/antiox12111928
Vancouver
Park JS, Rustamov N, Roh YS. The Roles of NRF2-Regulated Oxidative Stress and Mitochondrial Quality Control in Chronic Liver Diseases. Antioxidants. 2023;12(11):1928. doi:10.3390/antiox12111928
BibTeX
@article{Park2023,
author = {Park, Jeong-Su and Rustamov, Nodir and Roh, Yoon-Seok},
title = {The Roles of NRF2-Regulated Oxidative Stress and Mitochondrial Quality Control in Chronic Liver Diseases},
journal = {Antioxidants},
year = {2023},
volume = {12},
number = {11},
pages = {1928},
doi = {10.3390/antiox12111928}
}
EUVIMED